ライフサイエンスコーパス: pneumonectomy

1 maged units to surviving normal units (e.g., pneumonectomy).

2 sels 5 weeks after MCT injury (4 weeks after pneumonectomy).

3 ng adult alveolar regrowth following partial pneumonectomy.

4 who had previous contralateral lobectomy or pneumonectomy.

5 ed T2N0 NSCLC and had undergone lobectomy or pneumonectomy.

6 perioperative complications of extrapleural pneumonectomy.

7 cute lung injury, as do large breaths during pneumonectomy.

8 e, complete resection, pathologic stage, and pneumonectomy.

9 cted with MCT (60 mg/kg) on Day 7 after left pneumonectomy.

10 arteries obtained at transplant surgery and pneumonectomy.

11 cted with MCT (60 mg/kg) on Day 7 after left pneumonectomy.

12 monary artery blood flow after contralateral pneumonectomy.

13 onary artery anastomosis was substituted for pneumonectomy.

14 leurectomy and decortication or extrapleural pneumonectomy.

15 dge resection (12.5%), lobectomy (67.8%), or pneumonectomy (19.7%).

16 greater than 5 percent for esophagectomy and pneumonectomy, 2 to 5 percent for gastrectomy, cystectom

17 ents underwent lobectomy, 1 (3.2%) underwent pneumonectomy, 5 (16.1%) underwent sleeve lobectomy, and

18 Herein, we performed partial pneumonectomy, a model of lung regeneration, in mice lac

19 ial issues, such as the role of extrapleural pneumonectomy, adjuvant radiotherapy, and use of intensi

20 s was compared with animals receiving MCT or pneumonectomy alone.

21 hemotherapy in combination with extrapleural pneumonectomy - an emerging therapeutic option in the tr

22 Overcirculation was induced by pneumonectomy and by surgical creation of aortocaval fis

23 All patients who had undergone pneumonectomy and CT from January 2001 to August 2003, a

24 en shown in models of chronic hypoxia, after pneumonectomy and in some carcinomas.

25 ere felt to be associated with the operative pneumonectomy and pericardiotomy.

26 atients who have had a previous lobectomy or pneumonectomy and require thoracic surgery.

27 C57BL/6 J mice underwent left pneumonectomy and subcutaneous implantation of osmotic p

28 , cystectomy, esophagectomy, pancreatectomy, pneumonectomy, and liver resection) between 1993 and 200

29 ulmonary artery remodeling in these MCT plus pneumonectomy animals was compared with animals receivin

30 95% CI, 1.04-1.51; P = .02), and receipt of pneumonectomy (aOR, 1.35; 95% CI, 1.02-1.80; P = .04).

31 , and CPI were significantly increased after pneumonectomy at both time points in group P.

32 efusal of surgery or RT, n = 5; extrapleural pneumonectomy at time of surgery, n = 2; or chemotherapy

33 that received monocrotaline and/or underwent pneumonectomy but did not undergo aortocaval fistula, th

34 e, complete resection, pathologic stage, and pneumonectomy, but not induction regimen, significantly

35 ic mortality was substantially higher in the pneumonectomy cohort for both date of surgery and 1-year

36 hs (6.9% vs 1.9%; P = 0.002) were higher the pneumonectomy cohort.

37 timal lesions resulted from injury plus post-pneumonectomy compensatory lung growth, rather than inju

38 n was administered, followed by extrapleural pneumonectomy (EPP) and hemithoracic radiation (RT), to

39 iew our 24-year experience with extrapleural pneumonectomy (EPP) in the treatment of epithelioid mali

40 The effects of extra-pleural pneumonectomy (EPP) on survival and quality of life in p

41 he world's leading proponent of extrapleural pneumonectomy (EPP), an operation in which all the pleur

42 mplex cancer surgeries (pulmonary lobectomy, pneumonectomy, esophagectomy, gastrectomy, and colectomy

43 ompared to lobectomy, excess mortality after pneumonectomy extends beyond 1 year and is driven primar

44 tic resonance imaging underwent extrapleural pneumonectomy followed by combination chemotherapy and r

45 week-old, male, C57BL/6J mice underwent left pneumonectomy, followed by post-operative and daily intr

46 3) and control subjects (during lobectomy or pneumonectomy for cancer, n = 14).

47 the largest review of children who underwent pneumonectomy for cancer.

48 Patients undergoing lobectomy or pneumonectomy for lung cancer at our institution from 20

49 known about the indications and outcomes of pneumonectomy for pediatric tumors.

50 Twenty-six patients (68%) underwent pneumonectomy for primary tumors and 12 (32%) for metast

51 ents undergoing lung resection (lobectomy or pneumonectomy) for lung cancer.

52 tric patients <21 years of age who underwent pneumonectomy from 1990 to 2017 for primary or metastati

53 A 33-year-old woman underwent a right-sided pneumonectomy in 1995 for treatment of a lung adenocarci

54 es compensatory lung growth (CLG) after left pneumonectomy in a murine model.

55 KGF enhances compensatory lung growth after pneumonectomy in adult rats as indicated by increased LW

56 Pneumonectomy in adults is associated with significant m

57 Extrapleural pneumonectomy is a radical and aggressive surgery that p

58 Pneumonectomy is associated with profound changes in car

59 gic disruptions associated with extrapleural pneumonectomy is critical to effective management.

60 Anesthetic management of extrapleural pneumonectomy is further impacted by these developments.

61 el, that compensatory lung growth after left pneumonectomy is inhibited by heparin administration.

62 PURPOSE OF REVIEW: Pneumonectomy is still associated with a 5% 30-day morta

63 the 180 patients who underwent lobectomy or pneumonectomy led to the elimination of sex and age, whi

64 ere pulmonary hypertension by combining left pneumonectomy (LP) and chronic hypoxia (LP/Hx).

65 s in lung regeneration, we used a unilateral pneumonectomy model that promotes the formation of new a

66 34 months +/- 67 (standard deviation) after pneumonectomy; multiple CT scans were obtained in 58 pat

67 ction (n = 2), tube thoracostomy (n = 2), or pneumonectomy (n = 1) for diagnosis or treatment.

68 r invasion, two arterial stump thrombi after pneumonectomy, one artifact).

69 eated animals or in animals receiving MCT or pneumonectomy only.

70 carotid endarterectomy (CEA), lung lobectomy/pneumonectomy, open and laparoscopic cholecystectomy, pa

71 and RVH were similar whether injury preceded pneumonectomy or vice versa.

72 and pelvic exenteration (P=.04), but not for pneumonectomy (P=.32).

73 Forty-five pneumonectomy patients (18%) died of nononcologic causes

74 From 3339 lobectomy and 355 pneumonectomy patients identified, we derived 318 matche

75 Pneumonectomy patients require lifelong monitoring and m

76 In pneumonectomy patients, preexisting cardiac comorbidity

77 d trials are well under way for extrapleural pneumonectomy plus intraoperative intracavitary hyperthe

78 In small mammals, partial pneumonectomy (PNX) elicits rapid hyperplastic compensat

79 lt lung regeneration, we employ a unilateral pneumonectomy (PNX) model that promotes regenerative alv

80 Patients who have undergone pneumonectomy (PNX) show limited exercise capacity, part

81 pment and for compensatory lung growth after pneumonectomy (PNX), but the mechanisms by which strain

82 els in vigorously growing canine lungs after pneumonectomy (PNX), suggesting a role for paracrine EPO

83 primary or multifocal, second primary after pneumonectomy, proximal to or involved with mediastinal

84 Lobectomy or pneumonectomy should be performed in stage I NSCLC.

85 Pathological examination of each pneumonectomy specimen revealed a well-differentiated ad

86 ection of the tumor (usually by lobectomy or pneumonectomy), the patients were randomly assigned to r

87 After a right and left pneumonectomy, there was a significant difference betwee

88 atectomy time (dHT), without affecting donor pneumonectomy time (dPT), and influenced LiT and lung tr

89 awley rats was followed 1 week later by left pneumonectomy to increase blood flow to the right lung.

90 rgery for MPM has shifted from extra-pleural pneumonectomy to PDC with the goal of MCR.

91 Studies of long-term outcomes after pneumonectomy typically report generalized measures, suc

92 Describe a case of post-pneumonectomy vasoplegia managed with angiotensin II.

93 or patients who underwent lobectomy, but not pneumonectomy, versus chemotherapy plus radiotherapy.

94 imulates lung regeneration following partial pneumonectomy via direct transcriptional regulation of g

95 overall complications were similar (46% for pneumonectomy vs 43% for lobectomy; P = 0.40), but rates

96 Lobectomy or pneumonectomy vs sublobar resection.

97 ne 3% or propofol 8 to 10 mg/kg per hr until pneumonectomy was done; then propofol was used for all a

98 s were deemed ineligible if an unanticipated pneumonectomy was indicated, or if air leakage occurred

99 Left pneumonectomy was performed in group P, sham thoracotomy

100 Extrapleural pneumonectomy with adjuvant therapy is appropriate treat

101 oup P, sham thoracotomy in group S, and left pneumonectomy with administration of KGF (6.25 mg/week,

102 t options is the combination of extrapleural pneumonectomy with intraoperative intracavitary hyperthe

103 monstrated improved functional outcomes post-pneumonectomy with VEGF164 treatment.

104 y and characterize long-term consequences of pneumonectomy, with particular attention to nononcologic

105 ompared to wild type controls following left pneumonectomy without increased VEGF expression.